American Century Companies’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.67M | Buy |
208,301
+16,951
| +9% | +$216K | ﹤0.01% | 2028 |
|
|
2025
Q4 | $1.72M | Sell |
191,350
-58,815
| -24% | -$810K | ﹤0.01% | 2141 |
|
|
2025
Q3 | $4.32M | Sell |
250,165
-159,719
| -39% | -$1.97M | ﹤0.01% | 1778 |
|
|
2025
Q2 | $3.84M | Sell |
409,884
-61,792
| -13% | -$507K | ﹤0.01% | 1777 |
|
|
2025
Q1 | $3.35M | Buy |
471,676
+17,855
| +4% | +$180K | ﹤0.01% | 1774 |
|
|
2024
Q4 | $5.29M | Buy |
453,821
+15,385
| +4% | +$240K | ﹤0.01% | 1582 |
|
|
2024
Q3 | $9.01M | Buy |
438,436
+107,922
| +33% | +$2.49M | 0.01% | 1349 |
|
|
2024
Q2 | $7.4M | Buy |
330,514
+63,550
| +24% | +$1.51M | ﹤0.01% | 1369 |
|
|
2024
Q1 | $7.34M | Buy |
266,964
+18,435
| +7% | +$512K | ﹤0.01% | 1331 |
|
|
2023
Q4 | $7.58M | Sell |
248,529
-18,684
| -7% | -$537K | 0.01% | 1262 |
|
|
2023
Q3 | $8.45M | Buy |
267,213
+14,863
| +6% | +$577K | 0.01% | 1129 |
|
|
2023
Q2 | $10.3M | Sell |
252,350
-98,145
| -28% | -$3.98M | 0.01% | 1043 |
|
|
2023
Q1 | $13.1M | Buy |
350,495
+19,011
| +6% | +$746K | 0.01% | 912 |
|
|
2022
Q4 | $11.6M | Buy |
331,484
+63,361
| +24% | +$3.01M | 0.01% | 918 |
|
|
2022
Q3 | $15M | Buy |
268,123
+56,001
| +26% | +$3.47M | 0.01% | 748 |
|
|
2022
Q2 | $11M | Buy |
212,122
+138,524
| +188% | +$7.03M | 0.01% | 877 |
|
|
2022
Q1 | $5.35M | Sell |
73,598
-965
| -1% | -$81.8K | ﹤0.01% | 1094 |
|
|
2021
Q4 | $8.82M | Buy |
74,563
+2,864
| +4% | +$359K | 0.01% | 918 |
|
|
2021
Q3 | $9.62M | Buy |
71,699
+10,107
| +16% | +$1.53M | 0.01% | 852 |
|
|
2021
Q2 | $9.97M | Buy |
+61,592
| New | +$4.8M | 0.01% | 817 |
|
|
2017
Q3 | – | Sell |
-36,423
| Closed | -$583K | – | 1371 |
|
|
2017
Q2 | $583K | Buy |
+36,423
| New | +$509K | ﹤0.01% | 1210 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
